** Shares of drugmaker AbbVie ABBV.N rise 3.5% to $196 premarket
** AbbVie raises its annual adj. profit per share to between $11.88 and $12.08, from previous expectations of $11.67 to $11.87
** Company earned quarterly profit per share of $2.97 compared with analysts' average estimates of $2.88 per share - data compiled by LSEG
** AbbVie's second-quarter revenue came in at $15.42 billion vs estimate of $15.03 billion
** Skyrizi recorded Q2 sales of $4.42 billion, beating estimates of $4 billion while Rinvoq sales of $2.03 billion topped estimates of $1.97 billion
** Up to last close, stock up 6.5% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。